Sen. James Inhofe (R-OK) sold $1K-$15K of CRSP stock

James Inhofe, U.S. Senator (R-OK), disclosed a sale of CRISPR Therapeutics AG (CRSP) stock worth $1K-$15K in a STOCK Act filing on Jan 15, 2021.

The trade happened on Jan 5, 2021, 10 days before it was made public.

CRSP has moved -73.5% since the trade date, from $160.62 to $42.62 (Nov 12, 2026 close).